Recent Company News

• 09:04 AM ET Nov 05, 2025
  

  Swedish Orphan Biovitrum to present New One-Year Data on pegcetacoplan's efficacy in C3G and primary IC-MPGN and new outcome data on NASP at ASN Kidney Week (SEK 329.80, -2.60)

• 11:12 PM ET Nov 04, 2025
  

  Asahi Kasei to conduct up to 45M-share buyback for up to ¥40.0B from 6-Nov to 31-Oct (¥1182.5000, -25.5)

• 11:11 PM ET Nov 04, 2025
  

  Asahi Kasei reports H1 net income attributable ¥66.27B vs guidance ¥61.00B and FactSet ¥61B [1 est] (¥1193.5000, -14.5)

• 08:10 PM ET Oct 30, 2025
  

  Japan September retail sales +0.5% y/y, seasonally-adjusted retail sales +0.3% m/m

• 07:13 PM ET Oct 23, 2025
  

  StreetAccount Sector Preview - Japan Chemicals Jul-Sep Earnings

• 08:43 PM ET Oct 20, 2025
  

  Japan August electronics exports ¥1.152T, +1.6% y/y

• 06:47 PM ET Oct 16, 2025
  

  Asahi Kasei upgraded to outperform from neutral at Daiwa (¥1187.5000, 0)

• 04:43 AM ET Oct 14, 2025
  

  Asahi Kasei to buy 14.0% stake in RC Core as part of capital and business alliance; terms undisclosed (¥1162.0000, 0)

• 12:27 AM ET Oct 09, 2025
  

  NICE recommends Calliditas's Kinpeygo to treat primary immunoglobulin A (IgA) nephropathy in adults (¥1217.0000, +17.5)

• 11:31 AM ET Oct 08, 2025
  

  Asahi Kasei releases 2025 Integrated Report (¥1199.5000, 0)